Abstract:Radiation is one of the main methods for the treatment of colorectal cancer (CRC) before or after surgery. However, radiotherapy tolerance of patients with CRC is often a major concern. Interferon regulatory factor 1 (IRF1) is a member of the IRF family and is involved in the development of multiple diseases, including tumors. The present study investigated the role of IRF1 in the development and radiation sensitivity of CRC. Immunohistochemistry was performed to examine the expression levels of IRF1 in tissue samples from patients with CRC, as well as in nude mice. MTT, 5-ethynyl-20-deoxyuridine, colony formation, cell cycle alteration and apoptosis assays were performed in CRC cell lines. Western blotting and immunofluorescence were used to detect the expression levels of a series of proteins. RNA sequencing was applied to identify genes whose expression was upregulated by IRF1 overexpression. Xenograft nude mouse models and hematoxylin and eosin staining were used to validate the present findings in vivo. It was revealed that the expression levels of IRF1 were significantly lower in CRC tissues than in adjacent tissues. IRF1 upregulation inhibited cell proliferation and colony formation, caused G(1) cell arrest, promoted cell apoptosis, and enhanced the sensitivity of CRC cells to X-ray irradiation. The role of IRF1 in promoting the radiosensitivity of CRC was further demonstrated in nude mice with CRC xenografts. In addition, RNA sequencing revealed that overexpression of IRF1 in CRC cells significantly increased the expression levels of interferon-induced protein family members interferon alpha inducible protein 6, interferon induced transmembrane protein 1 and interferon induced protein 35 (fold change >2.0). In summary, the present study demonstrated that the upregulation of IRF1 inhibited the progression and promoted the radiosensitivity of CRC, likely by regulating interferon-induced proteins.

eIF3a Regulation of NHEJ Repair Protein Synthesis and Cellular Response to Ionizing Radiation

Effect of Eif3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating Dna Repair

eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage

The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair

Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma

Abstract 1749: Role of Eif3a in DNA Repair and Lung Cancer Chemo Sensitivity

IRF1 Regulates the Progression of Colorectal Cancer Via Interferon‑induced Proteins.

eIF3a‐PPP2R5A‐mediated ATM/ATR dephosphorylation is essential for irinotecan‐induced DNA damage response

Eif3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27 Kip1 translation

Translational Regulation of RPA2 Via Internal Ribosomal Entry Site and by Eif3a

Regulation of Protein Synthesis by Ionizing Radiation.

Eukaryotic Translation Initiation Factor 3 and Tumor

eIF3a: A new anticancer drug target in the eIF family.

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity

eIF3a Regulates Colorectal Cancer Metastasis via Translational Activation of RhoA and Cdc42

Nuclear distribution of eIF3g and its interacting nuclear proteins in breast cancer cells

Research progress on eIF3 a and cancer

Association Between Eif3α Polymorphism and Severe Toxicity Caused by Platinum‐based Chemotherapy in Non‐small Cell Lung Cancer Patients

DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity